← All trials
NCT01597934
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2012
- Primary completion
- May 1, 2014
- Completion date
- May 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 104
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Yonsei UniversityLead sponsor
- Yonsei UniversityOverall official - principal investigator
- Bristol-Myers SquibbCollaborator
- Catholic University of KoreaCollaborator
- Chonbuk National UniversityCollaborator
- Yonsei UniversityReponsible party - principal investigator
- Hallym UniversityCollaborator
- Kyungpook UniversityCollaborator
- Soonchunhyang UniversityCollaborator
- Pusan National UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.